Catechin, Hesperidin and Rutin Flavonoids: their Effects on Cardiovascular Health

Authors

  • Loipa Galán Martínez Universidad de Ciencias Médicas de La Habana. La Habana, Cuba. Instituto de Cardiología y Cirugía Cardiovascular, Departamento de Docencia e Investigaciones, Laboratorio de Electrofisiología Básica. https://orcid.org/0000-0002-0229-8934

Keywords:

flavonoids, cardiovascular, heart, catechin, hesperidin, rutin.

Abstract

Introduction: Flavonoids constitute a very diverse family of polyphenolic compounds that are biosynthesized in all terrestrial plants. Knowledge of the biological actions of these compounds has become of great interest to the scientific community, since they are consumed by humans with vegetables, infusions and wines. In this sense, flavonoids have shown highly esteemed properties in medicine, such as antimicrobial, anticarcinogenic, and in the reduction of the risk of cardiovascular diseases, among others.

Objectives: To review and update knowledge on flavonoids in general and, in particular, on catechin, hesperidin and rutin, since they are present in various vegetables and fruits, as well as their cardiovascular effects.

Methods: A review of the updated international literature was carried out. The search was carried out in Google Scholar and open access articles were consulted in the PubMed and SciELO databases. The following terms were used: cardiovascular, flavonoids, heart, catechin, hesperidin and rutin, according to the Health Sciences descriptor.

Results: A historical review of the discovery of these molecules and their advanced studies was performed, with emphasis on their effects on cardiovascular health.

Conclusions: The flavonoids catechin, hesperidin and rutin possess cardioprotective properties and biological effects related to cardiovascular health.

Downloads

Author Biography

Loipa Galán Martínez, Universidad de Ciencias Médicas de La Habana. La Habana, Cuba. Instituto de Cardiología y Cirugía Cardiovascular, Departamento de Docencia e Investigaciones, Laboratorio de Electrofisiología Básica.

Investigadora Titular

References

Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000 [acceso 22/01/2024];52:673-751. Disponible en: https://pubmed.ncbi.nlm.nih.gov/11121513/

Barreca MM, Alessandro R, Corrado C. Effects of flavonoids on cancer, cardiovascular and neurodegenerative diseases: Role of NF-κB signaling pathway. Int. J. Mol. Sci. 2023;24:9236. DOI: https://doi.org/10.3390/ijms24119236

Al-Khayri JM, Sahana GR, Nagella P, Joseph BV, Alessa FM, Al-Mssallem MQ. Flavonoids as potential anti-Inflammatory molecules: A review. Molecules 2022;27:2901. DOI: https://doi.org/10.3390/molecules27092901

Almeida B, Carvalho A, Cortes SF, Soares V. Vascular effects of flavonoids. Curr. Med. Chem. 2016 [acceso 22/01/2024];(1):87-102. Disponible en: https://benthamscience.com/article/71756

Martínez-Flórez S, González-Gallego J, Culebras JM, Tuñón MJ. Los flavonoides: propiedades y acciones antioxidantes. Nutr Hosp. 2002 [acceso 22/01/2024];17:271-8. Disponible en: http://www.nutricionhospitalaria.com/pdf/3338.pdf

Wright B, Spencer PE, Lovegrove A, Gibbins M. Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugs. Cardiovasc Res. 2013 [acceso 22/01/2024];97:13-22. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527766/

Fraga CG, Galleano M, Verstraeten SV, Oteiza PI. Basic biochemical mechanism behind the health benefits of polyphenols. Mol Asp Med. 2010 [acceso 22/01/2024];31:435-45. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20854840/

Salvamani S, Gunasekaran B, Shaharuddin NA, Ahmad SA, Shukor MY. Antiartherosclerotic effects of plant flavonoids. Biomed Res Int. 2014 [acceso 22/01/2024]:480258. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058282/

Fusi F, Trezza A, Tramaglino M, Sgaragli G, Saponara S, Spiga O. The beneficial health effects of flavonoids on the cardiovascular system: focus on K+ channels. Pharmacological Research. 2020. DOI: https://doi.org/10.1016/j.phrs.2019.104625

Tavan M, Hanachi P, de la Luz Cádiz-Gurrea M, Segura Carretero A, Mirjalili MH. Natural phenolic compounds with neuroprotective effects. Neurochem Res. 2024 [acceso 22/01/2024];49(2):306-26. DOI: https://doi.org/10.1007/s11064-023-04046-z

Pérez-Vizcaíno F, Duarte J. Flavonols and cardiovascular disease. Mol Asp Med. 2010 [acceso 22/01/2024];31:478-94. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20837053/

López JJ, Haouari EI, Jardin M, Alonso N, Regodón S, Diez-Bello R, et al. Flavonoids and platelet-derived thrombotic disorders. Curr Med Chem. 2019 [acceso 22/01/2024];26(39):7035-47. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29667548/

Yamagata K, Yamori Y. Inhibition of endothelial dysfunction by dietary flavonoids and preventive effects against cardiovascular disease. J Cardiovasc Pharmacol. 2020;75(1):1-9. DOI: https://doi:10.1097/FJC.0000000000000757

Schar MY, Curtis PS, Hazim S, Ostertag LM, Kay CD, Porter JF, et al. Orange juice–derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease. Am J Clin Nutr. 2015 [acceso 22/01/2024];101:931-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409690/

Álvarez-Collazo J, López-Requena A, Galán L, Talavera A, Álvarez JL, Talavera K. The citrus flavanone hesperetin preferentially inhibits slow‐inactivating currents of a long QT syndrome type 3 syndrome Na+ channel mutation. Br J Pharmacol. 2019;176(8):1090-1105. DOI: https://doi.org/10.1111/bph.14577

Scholz EP, Zitron E, Kiesecker C, Lück S, Thomas D, Kathöfer S, et al. Inhibition of cardiac HERG channels by grapefruit flavonoid naringenin: implications for the influence of dietary compounds on cardiac repolarization. Naunyn. Schmiedebergs Arch Pharmacol. 2005 [acceso 22/01/2024];371(6):516-25. Disponible en: https://link.springer.com/article/10.1007/s00210-005-1069-z

Zitron E, Scholz E, Owen RW, Lück S, Kiesecker C, Thomas D, et al. QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids. Circulation. 2005;111(7):835-8. DOI: https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000155617.54749.09

Saponara S, Fusi F, Iovinelli D, Ahmed A, Trezza A, Spiga O, et al. Flavonoids and hERG channels: Friends or foes? Eur J Pharmacol. 2021;15;899:174030. DOI: https://doi.org/10.1016/j.ejphar.2021.174030

Yang JY, Ma YX, Liu Y, Peng XJ, Chen XZ. A Comprehensive review of natural flavonoids with anti-SARS-CoV-2 activity. Molecules. 2023;17;28(6):27-35. DOI: https://doi.org/10.3390/molecules28062735

Dweck AC. The internal and external use of medicinal plants. Clin Dermatol. 2009 [acceso 22/01/2024];27:148-58. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19167996/

Isemura M. Catechin in human health and disease. Molecules. 2019;24(3):528. DOI: https://doi.org/10.3390/molecules24030528

Latos-Brozio M, Masek A. Structure-activity relationships analysis of monomeric and polymeric polyphenols (quercetin, rutin and catechin) obtained by various polymerization methods. Chem Biodivers. 2019;16(12):e1900426. DOI: https://doi.org/10.1002/cbdv.201900426

Galán Martínez L, Herrera Estrada I, Fleites Vázquez A. Cardiac effects of (−)- epigallocatechin on isolated rat hearts. Global J Med Res. 2018 [acceso 22/01/2024];18(2):21-4. Disponible en: https://globaljournals.org/GJMR_Volume18/4-Cardiac-Effects-of-Epigallocatechin.pdf

Guo J, Li K, Lin Y, Liu Y. Protective effects and molecular mechanisms of tea polyphenols on cardiovascular diseases. Front Nutr. 2023;28:10:1202378. DOI: https://doi.org/10.3389/fnut.2023.1202378

Jackson D, Connolly K, Batacan R, Ryan K, Vella R, Fenning A. (-)-Epicatechin reduces blood pressure and improves left ventricular function and compliance in deoxycorticosterone acetate-salt hypertensive rats. Molecules. 2018;23:1511. DOI: https://doi.org/10.3390/molecules23071511

Li JW, Wang XY, Zhang X, Gao L, Wang LF, Yin XH. (-)-Epicatechin protects against myocardial ischemia induced cardiac injury via activation of the PTEN/PI3K/AKT pathway. Mol Med Rep. 2018;17:8300-8. DOI: https://doi.org/10.3892/mmr.2018.8870

Lau SO, Georgousopoulou EN, Kellett J, Thomas J, McKune A, Mellor D, et al. The effect of dietary supplementation of green tea catechins on cardiovascular disease risk markers in humans: A systematic review of clinical trials. Beverages. 2016;2:16. DOI: https://doi.org/10.3390/beverages2020016

Ganeshpurkar A, Saluda AK. The pharmacological potential of rutin. Saudi Pharmac J. 2017 [acceso 22/01/2024];25:149-64. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355559/

Galán-Martínez L, Herrera-Estrada I, Fleites-Vázquez A. Direct actions of the flavonoids naringenin, quercetin and genistein on rat cardiac and vascular muscles. J Pharm Pharmacogn Res. 2018 [acceso 22/01/2024];6(3):158-66. Disponible en: https://www.redalyc.org/journal/4960/496055772003/html/

Bhandary B, Piao CS, Kim DS, Lee GH, Chae SW, Kim HR, et al. The Protective Effect of Rutin against Ischemia/reperfusion-associated Hemodynamic Alteration through Antioxidant Activity. Arch. Pharm. Res. 2012;35(6):1091-7. DOI: https://doi.org/10.1007/s12272-012-0617-6

Fei J, Sun Y, Duan Y, Xia J, Yu S, Ouyang P, et al. Low concentration of rutin treatment might alleviate the cardiotoxicity effect of pirarubicin on cardiomyocytes via activation of PI3K/AKT/mTOR signaling pathway. Biosc Rep. 2019;39. DOI: https://doi.org/10.1042/BSR20190546

Mahmoud AM, Hernández RJ, Sandhu MA, Hussein OE. Beneficial Effects of Citrus Flavonoids on Cardiovascular and Metabolic Health. Hindawi Oxidat Med Cell Long. 2019:5484138. DOI: https://onlinelibrary.wiley.com/doi/epdf/10.1155/2019/5484138

Wunpathe C, Potue P, Maneesai P, Bunbupha S, Prachaney P, Kukongviriyapan, et al. Hesperidin suppresses renin-angiotensin system mediated NOX2 overexpression and sympathoexcitation in 2K-1C hypertensive rats. Am J Chin Med. 2018;46(4):751-7. DOI: https://www.worldscientific.com/doi/10.1142/S0192415X18500398

Agrawal YO, Sharma PK, Shrivastava B, Ojha S, Upadhya HM, Arya DS, et al. Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic heart disease model in diabetic rats. PLoS ONE. 2014 [acceso 22/01/2024];9(11):e111212. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219710/

Yamamoto M, Suzuki A, Jokura H, Yamamoto N, Hase T. Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats. Nutrition 2008 [acceso 22/01/2024];24(5):470-6. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0899900708000336?via%3Dihub

Mohammadi M, Ramezani-Jolfaie N, Lorzadeh E, Khoshbakht Y, Salehi-Abargouei A. Hesperidin, a major flavonoid in orange juice, might not affect lipid profile and blood pressure: A systematic review and meta-analysis of randomized controlled clinical trials. Phytother Res. 2019 [acceso 22/01/2024];33:534-45. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30632207/

Pla-Pagá L, Companys J, Calderón-Pérez L, Llauradó E, Solá R, Valls RM, et al. Effects of hesperidin consumption on cardiovascular risk biomarkers: a systematic review of animal studies and human randomized clinical trials. Nutr. Rev. 2019;77(12):845-64. DOI: https://doi.org/10.1093/nutrit/nuz036

Álvarez-Collazo J, López-Medina AI, Rodríguez AA, Álvarez JL. Mechanism of the negative inotropic effect of naringin in mouse heart. J Pharm Pharmacogn Res. 2014 [acceso 22/01/2024];2(5):148-57. Disponible en: https://jppres.com/jppres/volume-2-issue-5-in-progress/

López-Medina AI, Álvarez-Collazo J, Rodríguez AA, Morón-Rodríguez F, Cabrera-Suárez H, Álvarez JL. Direct actions of naringin on rat cardiac and vascular smooth muscle. Bol Latinoam Caribe Plant Med Aromat. 2014 [acceso 22/01/2024];13:238-48. Disponible en: https://blacpma.ms-editions.cl/index.php/blacpma/issue/archive

Published

2025-02-17

How to Cite

1.
Galán Martínez L. Catechin, Hesperidin and Rutin Flavonoids: their Effects on Cardiovascular Health. Rev. cuba. cardiol. cir. cardiovasc. [Internet]. 2025 Feb. 17 [cited 2025 Apr. 3];31:e_2316. Available from: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/2316

Issue

Section

Review Article